Matt Zuga Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

Matt Zuga is CFO & Chief Business Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 209,951 shares of ABOS, which is worth approximately $373,712. The most recent transaction as insider was on Jan 08, 2026, when has been sold 6,888 shares (Common Stock) at a price of $1.82 per share, resulting in proceeds of $12,536. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K

9.4% 3M change

20.78% 12M change

Total Value Held $373,712

Matt Zuga Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2026	SELL Open market or private sale	$12,536 $1.82 p/Share	6,888 Reduced 3.18%	209,951 Common Stock
Jan 07 2026	SELL Open market or private sale	$11,610 $2.0 p/Share	5,805 Reduced 2.61%	216,839 Common Stock
Jan 06 2026	SELL Open market or private sale	$10,047 $1.97 p/Share	5,100 Reduced 2.24%	222,644 Common Stock
Jan 05 2026	SELL Open market or private sale	$7,840 $1.96 p/Share	4,000 Reduced 1.73%	227,744 Common Stock
Jan 23 2025	SELL Open market or private sale	$49,711 $1.72 p/Share	28,902 Reduced 11.09%	231,744 Common Stock
Jan 21 2025	SELL Open market or private sale	$6,982 $1.6 p/Share	4,364 Reduced 1.65%	260,646 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	66,800 Added 20.13%	265,010 Common Stock

Jan 03 2025	SELL Open market or private sale	$24,352 $1.84 p/Share	13,235 Reduced 6.26%	198,210 Common Stock
Jan 18 2024	SELL Open market or private sale	$15,695 $3.7 p/Share	4,242 Reduced 1.97%	211,445 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	106,000 Added 32.95%	215,687 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	33,500 Added 23.4%	109,687 Common Stock
Dec 29 2022	BUY Exercise of conversion of derivative security	$59,500 $1.19 p/Share	50,000 Added 39.62%	76,187 Common Stock
Jul 06 2021	BUY Conversion of derivative security	-	26,187 Added 50.0%	26,187 Common Stock

Also insider at

AZYO

AZIYO BIOLOGICS, INC. Healthcare

Matt Zuga

CFO & Chief Business Officer

Charlottesville, VA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Value

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Acumen Pharmaceuticals, Inc.

Track Activities on ABOS

Account